Effects of inhalation anaesthetics on the release of acetylcholine in the rat cerebral cortex in vivo

British Journal of Anaesthesia

Volumn 80, Issue 3, 1998, Pages 365-370

  Shichino, T ^a   Murakawa, M ^a   Adachi, T ^a   Arai, T ^a   Miyazaki, Y ^a   Mori, K ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anaesthetic gases, nitrous oxide; Anaesthetics volatile, isoflurane; Anaesthetics volatile, sevoflurane; Brain, cerebral cortex; Parasympathetic system, acetylcholine; Rat

Indexed keywords

ACETYLCHOLINE; INHALATION ANESTHETIC AGENT; ISOFLURANE; NITROUS OXIDE; SEVOFLURANE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CHOLINERGIC NERVE; CONTROLLED STUDY; DOSE RESPONSE; INHALATIONAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031929927     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/80.3.365     Document Type: Article

References (41)

1. Celesia GG, Jasper HH. Acetylcholine released from cerebral cortex in relation to state of activation. Neurology 1966; 16: 1053-1063.
2. Zucker J. Central cholinergic depression reduces MAC for isoflurane in rats. Anesthesia and Analgesia 1991; 72: 790-795.
3. Mori K, Winters WD. Neural background of sleep and anesthesia. International Anesthesia Clinics 1975; 13: 67-108.
4. Mori K. Anesthesia and brain functions. In: Gomes QJ, Egay LM, de la Cruz-Odi MF, eds. Proceedings of 8th World Congress of Anaesthesiology. Amsterdam: Excerpta Medica, 1984; 15-24.
5. Ogawa T, Shingu K, Shibata M, Osawa M, Mori K. The divergent actions of volatile anaesthetics on background neuronal activity and reactive capability in the central nervous system in cats. Canadian Journal of Anaesthesia 1992; 39: 862-872.
6. Osawa M, Shingu K, Murakawa M, Adachi T, Kurata J, Seo N, Murayama T, Nakao S, Mori K. Effects of sevoflurane on central nervous system electrical activity in cats. Anesthesia and Analgesia 1994; 79: 52-57.
7. Stevens JE, Oshima E, Mori K. Effects of nitrous oxide on the epileptogenic property of enflurane in cats. British Journal of Anaesthesia 1983; 55: 145-154.
8. Avramov MN, Shingu K, Mori K. Progressive changes in electroencephalographic responses to nitrous oxide in humans: a possible acute drug tolerance. Anesthesia and Analgesia 1990; 70: 369-374.
9. Murakawa M, Adachi T, Nakao S, Seo N, Shingu K, Mori K. Activation of the cortical and medullary dopaminergic systems by nitrous oxide in rats: a possible neurochemical basis for psychotropic effects and postanesthetic nausea and vomiting. Anesthesia and Analgesia 1994; 78: 376-381.
10. Berkowitz BA, Finck AD, Ngai SH. Nitrous oxide analgesia: reversal by naloxone and developement of tolerance. Journal of Pharmacology and Experimental Therapeutics 1977; 203: 539-547.
11. Berkowitz BA, Finck AD, Hynes MD, Ngai SH. Tolerance to nitrous oxide analgesia in rats and mice. Anesthesiology 1979; 51: 309-312.
12. Smith RA, Winter PM, Smith M, Eger EI II. Rapidly developing tolerance to acute exposures to anesthetic agents. Anesthesiology 1979; 50: 496-500.
13. Rupreht J, Dworacek B, Bonke B, Dzoljic MR, van Eijndhoven JHM, de Vlieger M. Tolerance to nitrous oxide in volunteers. Acta Anaesthesiologica Scandinavica 1985; 29: 635-638.
14. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd. Edn. San Diego, Carifornia: Academic Press, 1986.
15. Warner DS, McFarlen C, Todd MM, Ludwig P, McAllister AM. Sevoflurane and halothane reduce focal ischemic brain damage in the rat. Anesthesiology 1993; 79: 985-992.
16. Matsumura JS, Cole DJ, Schell RM, Wong MH. L-644,711, a novel anion transport inhibitor, increases isoflurane MAC in rats. Anesthesia and Analgesia 1991; 73: 199-203.
17. Gonsowski CT, Eger EI. Nitrous oxide minimum alveolar anesthetic concentration in rats is greater than previously reported. Anesthesia and Analgesia 1994; 79: 710-712.
18. Damsma G, Westerink BHC, Horn AS. A simple, sensitive, and economic assay for choline and acetylcholine using HPLC, an enzyme reactor, and an electrochemical detector. Journal of Neurochemistry 1985; 45: 1649-1652.
19. Phillis JW. Acetylcholine release from the cerebral cortex: its role in cortical arousal. Brain Research 1968; 7: 378-389.
20. Sato K, Wu J, Kikuchi T, Wang Y, Watanabe I, Okumura F. Differential effects of ketamine and pentobarbitone on acetylcholine release from rat hippocampus and striatum. British Journal of Anaesthesia 1996; 77: 381-384.
21. Bertorelli R, Hallström A, Hurd YL, Karlsson A, Consolo S, Ungerstedt U. Anaesthesia effects on in vivo acetylcholine transmission; comparisons of radioenzymatic and HPLC assays. European Journal of Pharmacology 1990; 175: 79-83.
22. Damsma G, Fibiger HC. The effects of anaesthesia and hypothermia on interstitial concentrations of acetylcholine and choline in rat striatum. Life Sciences 1991; 48: 2469-2474.
23. Whitwam JG, Morgan M, Hall GM, Petrie A. Pain during continuous nitrous oxide administration. Brtish Journal of Anaesthesia 1976; 48: 425-429.
24. Ramsay DS, Brown AC, Woods SC. Acute tolerance to nitrous oxide in humans. Pain 1992; 51: 367-373.
25. Dolin SJ, Little HJ. Effects of "nitrendipine" on nitrous oxide anesthesia, tolerance, and physical dependence. Anesthesiology 1989; 70: 91-97.
26. Ngai SH, Finck AD. Prolonged exposure to nitrous oxide decreases opiate receptor density in rat brainstem. Anesthesiology 1982; 57: 26-30.
27. 2O-induced alterations in somatosensory evoked potentials. Journal of Neurosurgical Anesthesiology 1989; 1: 91-95.
28. Dzoljic M, Rupreht J, Erdmann W, Stijnen TH, Briemen LJ, Dzoljic, MR. Behavioral and electrophysiological aspects of nitrous oxide dependence. Brain Research Bulletin 1994; 33: 25-31.
29. Shingu K, Osawa M, Fukuda K, Mori K. Acute tolerance to the analgesic action of nitrous oxide dose not develop in rats. Anesthesiology 1985; 62: 502-504.
30. Kawamoto T, Shingu K, Mori K. Effects of nitorus oxide on the somatosensory evoked response in cats. Journal of Anesthesia (Tokyo) 1990; 4: 51-60.
31. Fukunaga AF, Epstein RM. Sympathetic excitation during nitrous oxide-halothane anesthesia in the cat. Anesthesiology 1973; 39: 23-36.
32. Hornbein TF, Eger EI, Winter PM, Smith G, Wetstone D, Smith KH. The minimun alveolar concentration of nitrous oxide in man. Anesthesia and Analgesia 1982; 61: 553-556.
33. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment and prevention. Anesthesiology 1992; 77: 162-184.
34. Rupreht J, Dworacek B. Central anticholinergic syndrome in anesthetic practice. Ada Anaesthesiologica Belgica 1976; 27: 45-60.
35. Thompson DEA. Physostigmine as an adjuvant to neuroleptanaesthesia in neurosurgical procedures. Canadian Anaesthetists Society Journal 1976; 23: 582-586.
36. Hill GE, Stanley TH, Sentker CR. Physostigmine reversal of postoperative somnolence. Canadian Anaestheists Society Journal 1977; 24: 707-711.
37. Weinstock M, Davidson JT, Rosin AJ, Schmieden H. Effect of physostigmine on morphine-induced postoperative pain and somnolence. British Journal of Anaesthesia 1982; 54: 429-434.
38. Weinger MB, Swerdlow NR, Millar WL. Acute postoperative delirium and extrapyramidal signs in a previously healthy parturient. Anesthesia and Analgesia 1988; 67: 291-295.
39. Dehring DJ, Gupta B, Peruzzi WT. Postoperative opisthotonus and torticollis after fentanyl, enflurane, and nitrous oxide. Canadian Journal of Anaesthesia 1991; 38: 919-925.
40. Kesecioglu J, Rupreht J, Telci L, Dzoljic M, Erdmann W. Effect of aminophylline or physostigmine on recovery from nitrous oxide-enflurane anaesthesia. Acta Anaesthesiologica Scandinavica 1991; 35: 616-620.
41. Hamilton-Davies C, Bailie R, Restall J. Physostigmine in recovery from anaesthesia. Anaesthesia 1995; 50: 456-458.